Jianjun Chen from Corryton, TN, age 43

Resumes

Jianjun Chen

View page

Jianjun Chen

View page

Skills:

Customer Service
Microsoft Excel
Microsoft Word
Microsoft Office
Leadership

Jianjun Chen

View page

Jianjun Chen

View page

Location:

United States

Jianjun Chen San Jose, CA

View page

Work:

Mommsen Digon Capital Partners

Sep 2013 to 2000
Intern
Columbia University Center of Computational Biology and Bioinformatics
New York, NY
May 2013 to Aug 2013
Research Assistant
Python
New York, NY
Aug 2010 to Sep 2010

Education:

Columbia University, School of Engineering and Applied Science
New York, NY
Dec 2013
Master of Science in Chemical Engineering
China Pharmaceutical University, School of Pharmacy
Nanjing, CN
Jun 2012
B.S. in Pharmaceutics

Skills:

Python, Java, UNIX, Django, JQuery, JavaScript, Html, Ajax, CSS

Publications

Us Patents

Compounds For Treatment Of Cancer

View page

US Patent:

20180325872, Nov 15, 2018

Filed:

Jul 12, 2018

Appl. No.:

16/033953

Inventors:

- Knoxville TN, US
Jianjun Chen - Knoxville TN, US
Duane D. Miller - Collierville TN, US
Wei Li - Germantown TN, US

Assignee:

UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION - Knoxville TN

International Classification:

A61K 31/4178
A61K 31/337
A61K 31/437
A61K 31/4174
A61K 31/519
A61K 31/506
A61K 31/4164
A61K 31/335
A61K 31/435
A61K 31/42

Abstract:

The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, RO5068760), in combination with anti-tubulin compounds of the invention or other known tubulin inhibitors, and using such compositions for treating cancer such as melanoma, drug-resistant cancer, and cancer metastasis.